Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis
Ashina, Messoud, Mitsikostas, Dimos D., Ramirez Campos, Verena, Barash, Steve, Ning, Xiaoping, Diener, Hans‐Christoph
Published in Headache (01.11.2023)
Published in Headache (01.11.2023)
Get full text
Journal Article
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study
Ahmed, Zubair, Honomichl, Ryan, Thompson, Stephen F., Cohen, Joshua M., Schuster, Andrew, Thompson, Nicolas R., Lapin, Brittany, Udeh, Belinda L., Ramirez Campos, Verena, Krasenbaum, Lynda J., Katzan, Irene L.
Published in Headache (01.07.2023)
Published in Headache (01.07.2023)
Get full text
Journal Article
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study
Spierings, Egilius L. H., Ning, Xiaoping, Ramirez Campos, Verena, Cohen, Joshua M., Barash, Steve, Buse, Dawn C.
Published in Headache (01.10.2021)
Published in Headache (01.10.2021)
Get full text
Journal Article
Efficacy and quality‐of‐life improvements with fremanezumab treatment in patients with difficult‐to‐treat migraine with associated neurological dysfunction
Lampl, Christian, Rapoport, Alan M., Cohen, Joshua M., Barash, Steve, Ramirez Campos, Verena, Seminerio, Michael J., Ning, Xiaoping, Silberstein, Stephen D.
Published in European journal of neurology (01.07.2022)
Published in European journal of neurology (01.07.2022)
Get full text
Journal Article
Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020
Barash, Steve, Ramirez Campos, Verena, Ning, Xiaoping, Driessen, Maurice T., Krasenbaum, Lynda J., Carr, Karen, Cohen, Joshua M.
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.11.2021)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.11.2021)
Get full text
Journal Article
085 Medication overuse reversion following fremanezumab treatment in migraine patients with inadequate response to prior preventives
Ashina, Sait, Campos, Verena Ramirez, Cohen, Joshua, Janka, Lindsay, Krasenbaum, Lynda, Blume, Lydia
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Get full text
Journal Article
086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes
Naegel, Steffen, Cohen, Joshua, Campos, Verena Ramirez, Barash, Steve, Ning, Xiaoping, Dhiraj, Dalbir, Kudrow, David
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Get full text
Journal Article
056 Efficacy of fremanezumab in chronic migraine patients with inadequate response to ≥3 preventive medication classes
Lambru, Giorgio, Dhiraj, Dalbir, Ning, Xiaoping, Campos, Verena Ramirez, Barash, Steve, Sherwin, Eoin, Cohen, Joshua
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2022)
Get full text
Journal Article
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
Lipton, Richard B., Cohen, Joshua M., Bibeau, Kristen, Galic, Maja, Seminerio, Michael J., Ramirez Campos, Verena, Halker Singh, Rashmi B., Ailani, Jessica
Published in Headache (01.11.2020)
Published in Headache (01.11.2020)
Get full text
Journal Article
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Ashina, Messoud, Mitsikostas, Dimos D., Amin, Faisal Mohammad, Kokturk, Pinar, Schankin, Christoph J., Sahin, Gurdal, Pozo-Rosich, Patricia, Dorman, Paul J., Nežádal, Tomáš, Poole, Anne Christine, Martins, Isabel Pavão, Sumelahti, Marja-Liisa, Ramirez Campos, Verena, Ahn, Andrew H., Lyras, Leonidas, Tassorelli, Cristina
Published in Cephalalgia (01.11.2023)
Published in Cephalalgia (01.11.2023)
Get full text
Journal Article
Immunogenicity of biologic therapies for migraine: a review of current evidence
Cohen, Joshua M., Ning, Xiaoping, Kessler, Yoel, Rasamoelisolo, Michele, Campos, Verena Ramirez, Seminerio, Michael J., Krasenbaum, Lynda J., Shen, Honglue, Stratton, Jennifer
Published in Journal of headache and pain (07.01.2021)
Published in Journal of headache and pain (07.01.2021)
Get full text
Journal Article
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study
Ashina, Messoud, Cohen, Joshua M., Galic, Maja, Campos, Verena Ramirez, Barash, Steve, Ning, Xiaoping, Kessler, Yoel, Janka, Lindsay, Diener, Hans-Christoph
Published in Journal of headache and pain (01.12.2021)
Published in Journal of headache and pain (01.12.2021)
Get full text
Journal Article
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
McAllister, Peter, Cohen, Joshua M., Campos, Verena Ramirez, Ning, Xiaoping, Janka, Lindsay, Barash, Steve
Published in Journal of headache and pain (29.08.2022)
Published in Journal of headache and pain (29.08.2022)
Get full text
Journal Article
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (24.11.2021)
Published in Journal of headache and pain (24.11.2021)
Get full text
Journal Article
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
MaassenVanDenBrink, Antoinette, Terwindt, Gisela M., Cohen, Joshua M., Barash, Steve, Campos, Verena Ramirez, Galic, Maja, Ning, Xiaoping, Kärppä, Mikko
Published in Journal of headache and pain (18.12.2021)
Published in Journal of headache and pain (18.12.2021)
Get full text
Journal Article
Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine
Mackenzie, Kimberly D, Ortega, Mario, Kessler, Yoel, Campos, Verena Ramirez, Krasenbaum, Lynda J, Carr, Karen, Ning, Xiaoping, Stratton, Jennifer
Published in Frontiers in physiology (29.11.2022)
Published in Frontiers in physiology (29.11.2022)
Get full text
Journal Article
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
Buse, Dawn C., Gandhi, Sanjay K., Cohen, Joshua M., Ramirez-Campos, Verena, Cloud, Blaine, Yang, Ronghua, Cowan, Robert P.
Published in Journal of headache and pain (04.09.2020)
Published in Journal of headache and pain (04.09.2020)
Get full text
Journal Article
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (17.05.2022)
Published in Journal of headache and pain (17.05.2022)
Get full text
Journal Article
Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: Results of the UNITE study
Mcallister, Peter, Campos, Verena Ramirez, Arie, Zipora Roth-Ben, Krasenbaum, Lynda, Ning, Xiaoping, Galic, Maja, Mitsikostas, Dimos
Published in Journal of the neurological sciences (01.12.2023)
Published in Journal of the neurological sciences (01.12.2023)
Get full text
Journal Article